BOSTON – For those in obesity treatment, things are looking up, said Reem Z. Sharaiha, MD, MSc, in a video interview at the AGA Tech Summit, sponsored by the AGA Center for GI Innovation and Technology. There are several new therapies to choose from, said Dr. Sharaiha, assistant professor of medicine at Cornell University, New York – and a variety of therapies coming down the pipeline. The key is to choose the right treatment, or right combination of treatments – surgical, endoscopic, or medical – for the right patient at the right time and to follow up. Obesity is a chronic disease that needs long-term, team treatment. With obesity treatments there is sometimes a trade-off between risk and results, but the innovations coming along may balance that risk-results equation for some patients, she said.
AGA Tech Summit
VIDEO: It is an exciting time in obesity treatment
Publish date: March 23, 2018
REPORTING FROM 2018 AGA TECH SUMMIT
Vidyard Video
More Obesity News
- Experts offer guidance on GLP-1 receptor agonists prior to endoscopy
- GLP-1 agonists linked to higher risk for rare but serious GI complications
- Obesity in GI care
- FDA gives semaglutide two drug safety–related label changes
- Gastroenterology Data Trends 2023
- Landmark obesity legislation reintroduced in Congress
- Study documents obesity-related defecation disorders
- Poor weight loss after bariatric surgery? Liraglutide may help
AGA Update: Bariatric surgery in patients with cirrhosis
Question 1 of 4